期刊文献+

多发性骨髓瘤伴肾损害38例临床分析 被引量:5

暂未订购
导出
摘要 目的总结多发性骨髓瘤(MM)伴肾损害的临床特征。方法回顾性分析38例MM伴肾损害患者的临床资料。结果MM伴肾损害患者中临床症候群以肾功能不全(血肌酐≥133μmol/L)最常见(84.21%),其次为肾病综合征(10.53%)和无症状性尿蛋白阳性(5.26%);患者贫血发生率高(92.11%);高血压发生率低(18.42%);高钙血症发生率为28.95%,高血钙患者有更严重的肾功能不全、贫血、高球蛋白血症,差异有统计学意义(P<0.05);血清M蛋白阳性率为71.05%;溶骨性病变占68.80%;尿液轻链阳性率为63.16%,以λ轻链为主;尿本-周蛋白阳性率为47.37%;B超显示:左肾(104±9.5)mm、右肾(101±10.2)mm,表明双肾均无显著缩小。结论MM伴肾损害患者临床上以肾功能不全最常见,尿液中以λ轻链为主,同时常伴有严重贫血、高钙血症、血压不高、双肾缩小不显著等特点。
出处 《苏州大学学报(医学版)》 CAS 北大核心 2008年第4期636-637,共2页 Suzhou University Journal of Medical Science
  • 相关文献

参考文献8

  • 1Winearls CG.Acute myeloma kidney[J]. Kidney Int,1995, 48(4):1347-1361.
  • 2Carli PM,Coebergh JW,Verdecchia A. Variation in survival of adult patients with haematological malignancies in Europe since 1978[J]. Eur J Cancer, 1998, 34(14): 2253-2263.
  • 3侯仰韶,陈泽涛,孟振华,张永奎.多发性骨髓瘤322例误诊资料分析[J].中国实用内科杂志,2005,25(8):757-758. 被引量:15
  • 4Blade J,Fernandez-Llama P,Bosch F, et ol. Renal failure in multiple myeloma:Presenting features and predictors of outcome in 94 patients from a single institutlon[J]. Arch Intern Med,1998,158(17):1889-1893.
  • 5Irish AB, Winearls CG, Littlewood T. Presentation and Survival of patients with severe renal failure eand myeloma[J]. QJM, 1997,90(12):773-780.
  • 6Alexanian R,Barlogie B,Dixon D. Renal failure in multiple myeloma pathogenesis and prognostic implications [J]. Arch Intern Med,1991,150(8):1693-1695.
  • 7Seema B,Gerald S,Agnes B. Multiple complications in multiple myeloma[J]. American Journal of Kidney Diseases, 2005,45(11):619-623.
  • 8Montseny JJ,kleinknecht D,Meyrier A,et ol. Long-term outcome according to renal histological lesions in 118 patients with multiple myeloma[J]. Nephrol Dial Transplant, 1998,13(6):1438-1445.

二级参考文献16

共引文献14

同被引文献35

  • 1陈曼娜,肖亮生,韩丽君.多发性骨髓瘤患者骨髓象及外周血象分析[J].吉林医学,2005,26(6):613-614. 被引量:3
  • 2姚翠微,刘华锋,梁东,陈孝文.多发性骨髓瘤肾损害临床与病理特征分析[J].中国中西医结合肾病杂志,2006,7(5):279-280. 被引量:5
  • 3林爱武,李校,葛立.多发性骨髓瘤肾损害误诊临床分析[J].中国中西医结合肾病杂志,2007,8(3):169-170. 被引量:4
  • 4A1-Mueilo SH, Al-Amri AM. Renal failure in patients with multiple myeloma: a single center experience. Saudi Med J, 2008, 29(3): 466-468.
  • 5Matsue K, Fujiwara H, lwama K, et al. Reversal of dialysisdependent renal failure in patients with advanced multiple myeloma: single institutional experiences over 8 years. Ann Hematol, 2010, 89(3): 291-297.
  • 6Tsakiris D J, Stel VS, Finne P, et al. Incidence and outcome of patients starting renal replacement therapy for endstage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrol Dial Transplant, 2010, 25(4): 1200-1206.
  • 7Schiemann U, Kaiser HC, Gotzberger M, et al. Determination of intrarenal resistance index (RI) in patients with multiple myeloma. Eur J Med Res, 2010, 15(5): 210-213.
  • 8Dimopoulos MA, Kastritis E, Rosinol L, et al. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia, 2008, 22(8): 1485-1493.
  • 9International Myeloma Working Group.Criteria for the classification of monoclonal gammopathies,multiple myeloma and related disorders:a report of the International Myeloma Working Group[J].Br J Haematol,2003,121(5):749-757.
  • 10Subramanian R,Basu D,Dutta TK.Prognostic significance of bone marrow histology in multiple myeloma[J].Indian J Cancer,2009,46(1):40-45.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部